DTS 201

Drug Profile

DTS 201

Alternative Names: CPI 0004; CPI 0004Na; Super-Leu-Dox

Latest Information Update: 12 Feb 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medarex
  • Developer Diatos
  • Class Anthracyclines; Antineoplastics; Doxorubicins
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Breast cancer; Prostate cancer

Most Recent Events

  • 30 Sep 2009 Phase-II clinical trials in Breast cancer in Europe (IV)
  • 30 Sep 2009 Phase-II clinical trials in Prostate cancer in Europe (IV)
  • 23 Oct 2007 Data presented at the 19th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2007) added to the adverse events and Cancer therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top